Driving Long-Term ELN Adoption in Biopharma R&D After Implementation
In biopharma research and drug discovery, electronic lab notebooks (ELNs) have become essential digital tools for documenting experiments, maintaining traceability, and supporting reproducible science. ELN implementations are typically well planned, validated, and executed, with clear milestones and objectives. However, for many labs, the most challenging phase begins after deployment, when responsibility shifts from technical readiness to effective, meaningful use.
While researchers may initially follow new documentation requirements, inconsistent usage patterns often emerge. Some scientists fully adopt the system, while others revert to spreadsheets, local files, or paper notes. As a result, protocols diverge, data quality varies, and key stakeholders lose visibility into projects. Achieving long-term value from an electronic lab notebook, therefore, requires sustained operational focus, not just successful deployment.
Read More
